These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
402 related articles for article (PubMed ID: 24058406)
21. Alpha-synuclein seeds in olfactory mucosa of patients with isolated REM sleep behaviour disorder. Stefani A; Iranzo A; Holzknecht E; Perra D; Bongianni M; Gaig C; Heim B; Serradell M; Sacchetto L; Garrido A; Capaldi S; Sánchez-Gómez A; Cecchini MP; Mariotto S; Ferrari S; Fiorini M; Schmutzhard J; Cocchiara P; Vilaseca I; Brozzetti L; Monaco S; Jose Marti M; Seppi K; Tolosa E; Santamaria J; Högl B; Poewe W; Zanusso G; Brain; 2021 May; 144(4):1118-1126. PubMed ID: 33855335 [TBL] [Abstract][Full Text] [Related]
22. The role of innate immunity and inflammation in Parkinson´s disease. Öberg M; Fabrik I; Fabrikova D; Zehetner N; Härtlova A Scand J Immunol; 2021 May; 93(5):e13022. PubMed ID: 33471378 [TBL] [Abstract][Full Text] [Related]
23. MerTK is a mediator of alpha-synuclein fibril uptake by human microglia. Dorion MF; Yaqubi M; Senkevich K; Kieran NW; MacDonald A; Chen CXQ; Luo W; Wallis A; Shlaifer I; Hall JA; Dudley RWR; Glass IA; ; Stratton JA; Fon EA; Bartels T; Antel JP; Gan-Or Z; Durcan TM; Healy LM Brain; 2024 Feb; 147(2):427-443. PubMed ID: 37671615 [TBL] [Abstract][Full Text] [Related]
24. Elevated alpha-synuclein mRNA levels in individual UV-laser-microdissected dopaminergic substantia nigra neurons in idiopathic Parkinson's disease. Gründemann J; Schlaudraff F; Haeckel O; Liss B Nucleic Acids Res; 2008 Apr; 36(7):e38. PubMed ID: 18332041 [TBL] [Abstract][Full Text] [Related]
25. Age-dependent defects of alpha-synuclein oligomer uptake in microglia and monocytes. Bliederhaeuser C; Grozdanov V; Speidel A; Zondler L; Ruf WP; Bayer H; Kiechle M; Feiler MS; Freischmidt A; Brenner D; Witting A; Hengerer B; Fändrich M; Ludolph AC; Weishaupt JH; Gillardon F; Danzer KM Acta Neuropathol; 2016 Mar; 131(3):379-91. PubMed ID: 26576561 [TBL] [Abstract][Full Text] [Related]
26. Peripheral Inflammation Regulates CNS Immune Surveillance Through the Recruitment of Inflammatory Monocytes Upon Systemic α-Synuclein Administration. Peralta Ramos JM; Iribarren P; Bousset L; Melki R; Baekelandt V; Van der Perren A Front Immunol; 2019; 10():80. PubMed ID: 30761145 [TBL] [Abstract][Full Text] [Related]
27. Microglia and astrocyte activation is region-dependent in the α-synuclein mouse model of Parkinson's disease. Basurco L; Abellanas MA; Ayerra L; Conde E; Vinueza-Gavilanes R; Luquin E; Vales A; Vilas A; Martin-Uriz PS; Tamayo I; Alonso MM; Hernaez M; Gonzalez-Aseguinolaza G; Clavero P; Mengual E; Arrasate M; Hervás-Stubbs S; Aymerich MS Glia; 2023 Mar; 71(3):571-587. PubMed ID: 36353934 [TBL] [Abstract][Full Text] [Related]
28. miR-let-7a suppresses α-Synuclein-induced microglia inflammation through targeting STAT3 in Parkinson's disease. Zhang J; Dongwei Zhou ; Zhang Z; Xinhui Qu ; Kunwang Bao ; Guohui Lu ; Jian Duan Biochem Biophys Res Commun; 2019 Nov; 519(4):740-746. PubMed ID: 31547989 [TBL] [Abstract][Full Text] [Related]
30. Alpha-Synuclein as a Prominent Actor in the Inflammatory Synaptopathy of Parkinson's Disease. Cardinale A; Calabrese V; de Iure A; Picconi B Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34204581 [TBL] [Abstract][Full Text] [Related]
32. Naturally occurring autoantibodies against α-synuclein rescues memory and motor deficits and attenuates α-synuclein pathology in mouse model of Parkinson's disease. Huang YR; Xie XX; Ji M; Yu XL; Zhu J; Zhang LX; Liu XG; Wei C; Li G; Liu RT Neurobiol Dis; 2019 Apr; 124():202-217. PubMed ID: 30481547 [TBL] [Abstract][Full Text] [Related]
33. Regionally-specific microglial activation in young mice over-expressing human wildtype alpha-synuclein. Watson MB; Richter F; Lee SK; Gabby L; Wu J; Masliah E; Effros RB; Chesselet MF Exp Neurol; 2012 Oct; 237(2):318-34. PubMed ID: 22750327 [TBL] [Abstract][Full Text] [Related]
34. Microglial activation and antioxidant responses induced by the Parkinson's disease protein α-synuclein. Béraud D; Hathaway HA; Trecki J; Chasovskikh S; Johnson DA; Johnson JA; Federoff HJ; Shimoji M; Mhyre TR; Maguire-Zeiss KA J Neuroimmune Pharmacol; 2013 Mar; 8(1):94-117. PubMed ID: 23054368 [TBL] [Abstract][Full Text] [Related]
35. Inhibition of the JAK/STAT Pathway Protects Against α-Synuclein-Induced Neuroinflammation and Dopaminergic Neurodegeneration. Qin H; Buckley JA; Li X; Liu Y; Fox TH; Meares GP; Yu H; Yan Z; Harms AS; Li Y; Standaert DG; Benveniste EN J Neurosci; 2016 May; 36(18):5144-59. PubMed ID: 27147665 [TBL] [Abstract][Full Text] [Related]
37. Parkinson's disease and alpha synuclein: is Parkinson's disease a prion-like disorder? Olanow CW; Brundin P Mov Disord; 2013 Jan; 28(1):31-40. PubMed ID: 23390095 [TBL] [Abstract][Full Text] [Related]
38. NK cells clear α-synuclein and the depletion of NK cells exacerbates synuclein pathology in a mouse model of α-synucleinopathy. Earls RH; Menees KB; Chung J; Gutekunst CA; Lee HJ; Hazim MG; Rada B; Wood LB; Lee JK Proc Natl Acad Sci U S A; 2020 Jan; 117(3):1762-1771. PubMed ID: 31900358 [TBL] [Abstract][Full Text] [Related]
39. The relation between α-synuclein and microglia in Parkinson's disease: Recent developments. Sanchez-Guajardo V; Tentillier N; Romero-Ramos M Neuroscience; 2015 Aug; 302():47-58. PubMed ID: 25684748 [TBL] [Abstract][Full Text] [Related]
40. CD4 T cells mediate brain inflammation and neurodegeneration in a mouse model of Parkinson's disease. Williams GP; Schonhoff AM; Jurkuvenaite A; Gallups NJ; Standaert DG; Harms AS Brain; 2021 Aug; 144(7):2047-2059. PubMed ID: 33704423 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]